Preliminary data assessing change in left ventricular ejection fraction of patients initiated on SGLT2 inhibitor therapy, an ongoing observational study.
Event:
Heart Failure 2022
Topic:
Pharmacotherapy
Session:
Heart Failure ePosters - focus on Chronic Heart Failure 2
